125 related articles for article (PubMed ID: 8792328)
1. Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease.
Greenfield S
Neurochem Int; 1996; 28(5-6):485-90. PubMed ID: 8792328
[No Abstract] [Full Text] [Related]
2. Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease.
Layer PG
Neurochem Int; 1996; 28(5-6):491-5. PubMed ID: 8792329
[No Abstract] [Full Text] [Related]
3. Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease.
Small DH; Michaelson S; Sberna G
Neurochem Int; 1996; 28(5-6):453-83. PubMed ID: 8792327
[TBL] [Abstract][Full Text] [Related]
4. Non-hydrolytic functions of acetylcholinesterase. The significance of C-terminal peptides.
Greenfield SA; Zimmermann M; Bond CE
FEBS J; 2008 Feb; 275(4):604-11. PubMed ID: 18205834
[TBL] [Abstract][Full Text] [Related]
5. Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease.
Geula C; Mesulam M
Brain Res; 1989 Sep; 498(1):185-9. PubMed ID: 2790472
[TBL] [Abstract][Full Text] [Related]
6. Cholinesterases colocalize with sites of neurofibrillary degeneration in aged and Alzheimer's brains.
Morán MA; Mufson EJ; Gómez-Ramos P
Acta Neuropathol; 1994; 87(3):284-92. PubMed ID: 8009960
[TBL] [Abstract][Full Text] [Related]
7. Cholinesterases in cerebrospinal fluid. Correlations with clinical measures in Alzheimer's disease.
Huff FJ; Maire JC; Growdon JH; Corkin S; Wurtman RJ
J Neurol Sci; 1986 Feb; 72(2-3):121-9. PubMed ID: 3711929
[TBL] [Abstract][Full Text] [Related]
8. Shifting patterns of cortical cholinesterases in Alzheimer's disease: implications for treatment, diagnosis, and pathogenesis.
Mesulam MM; Geula C
Adv Neurol; 1990; 51():235-40. PubMed ID: 2403715
[No Abstract] [Full Text] [Related]
9. Molecular forms of cholinesterases in CSF of Alzheimer's disease/senile dementia of Alzheimer type patients and matched neurological controls.
Bisso GM; Masullo C; Michalek H; Silveri MC; Pocchiari M
Life Sci; 1986 Feb; 38(6):561-7. PubMed ID: 3945178
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Preliminary Evaluation of Phenyl 4-123I-Iodophenylcarbamate for Visualization of Cholinesterases Associated with Alzheimer Disease Pathology.
Macdonald IR; Reid GA; Pottie IR; Martin E; Darvesh S
J Nucl Med; 2016 Feb; 57(2):297-302. PubMed ID: 26541777
[TBL] [Abstract][Full Text] [Related]
11. Protease inhibitors and indolamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer's disease.
Wright CI; Geula C; Mesulam MM
Ann N Y Acad Sci; 1993 Sep; 695():65-8. PubMed ID: 8239315
[TBL] [Abstract][Full Text] [Related]
12. The significance of the activity of CSF cholinesterases in dementias.
Shen ZX
Med Hypotheses; 1996 Nov; 47(5):363-76. PubMed ID: 8951800
[TBL] [Abstract][Full Text] [Related]
13. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
Wright CI; Geula C; Mesulam MM
Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
[TBL] [Abstract][Full Text] [Related]
14. Cholinesterases within neurofibrillary tangles related to age and Alzheimer's disease.
Mesulam MM; Asuncion Morán M
Ann Neurol; 1987 Aug; 22(2):223-8. PubMed ID: 3662453
[TBL] [Abstract][Full Text] [Related]
15. Some cerebral proteins and enzyme systems in Alzheimer's presenile and senile dementia.
Op den Velde W; Stam FC
J Am Geriatr Soc; 1976 Jan; 24(1):12-6. PubMed ID: 1244383
[TBL] [Abstract][Full Text] [Related]
16. [Cholinesterases and their importance in the etiology, diagnosis and therapy of Alzheimer's disease].
Patocka J; Strunecká A; Rípová D
Cesk Fysiol; 2001 Feb; 50(1):4-10. PubMed ID: 11268561
[TBL] [Abstract][Full Text] [Related]
17. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
[TBL] [Abstract][Full Text] [Related]
18. Cholinesterases, a target of pharmacology and toxicology.
Pohanka M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):219-29. PubMed ID: 22286807
[TBL] [Abstract][Full Text] [Related]
19. Molecular perception of interactions between bis(7)tacrine and cystamine-tacrine dimer with cholinesterases as the promising proposed agents for the treatment of Alzheimer's disease.
Eslami M; Hashemianzadeh SM; Bagherzadeh K; Seyed Sajadi SA
J Biomol Struct Dyn; 2016; 34(4):855-69. PubMed ID: 26043757
[TBL] [Abstract][Full Text] [Related]
20. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C
Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
